rs17880604

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000546.6(TP53):​c.673-36G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0155 in 1,303,868 control chromosomes in the GnomAD database, including 223 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 17 hom., cov: 30)
Exomes 𝑓: 0.016 ( 206 hom. )

Consequence

TP53
NM_000546.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -1.50

Publications

24 publications found
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
TP53 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Li-Fraumeni syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Li-Fraumeni syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • adrenocortical carcinoma, hereditary
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • bone marrow failure syndrome 5
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • colorectal cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • choroid plexus carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 17-7674326-C-G is Benign according to our data. Variant chr17-7674326-C-G is described in ClinVar as Benign. ClinVar VariationId is 221184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0117 (1760/150704) while in subpopulation NFE AF = 0.0193 (1308/67818). AF 95% confidence interval is 0.0184. There are 17 homozygotes in GnomAd4. There are 815 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 1760 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
NM_000546.6
MANE Select
c.673-36G>C
intron
N/ANP_000537.3
TP53
NM_001126112.3
c.673-36G>C
intron
N/ANP_001119584.1K7PPA8
TP53
NM_001407262.1
c.673-36G>C
intron
N/ANP_001394191.1K7PPA8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
ENST00000269305.9
TSL:1 MANE Select
c.673-36G>C
intron
N/AENSP00000269305.4P04637-1
TP53
ENST00000445888.6
TSL:1
c.673-36G>C
intron
N/AENSP00000391478.2P04637-1
TP53
ENST00000610292.4
TSL:1
c.556-36G>C
intron
N/AENSP00000478219.1P04637-4

Frequencies

GnomAD3 genomes
AF:
0.0117
AC:
1760
AN:
150688
Hom.:
17
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00268
Gnomad AMI
AF:
0.0286
Gnomad AMR
AF:
0.00970
Gnomad ASJ
AF:
0.0145
Gnomad EAS
AF:
0.000390
Gnomad SAS
AF:
0.00524
Gnomad FIN
AF:
0.00539
Gnomad MID
AF:
0.0392
Gnomad NFE
AF:
0.0193
Gnomad OTH
AF:
0.0131
GnomAD2 exomes
AF:
0.0122
AC:
3054
AN:
250078
AF XY:
0.0126
show subpopulations
Gnomad AFR exome
AF:
0.00247
Gnomad AMR exome
AF:
0.00709
Gnomad ASJ exome
AF:
0.0166
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00452
Gnomad NFE exome
AF:
0.0202
Gnomad OTH exome
AF:
0.0149
GnomAD4 exome
AF:
0.0160
AC:
18466
AN:
1153164
Hom.:
206
Cov.:
17
AF XY:
0.0158
AC XY:
9282
AN XY:
587594
show subpopulations
African (AFR)
AF:
0.00291
AC:
80
AN:
27458
American (AMR)
AF:
0.00760
AC:
336
AN:
44222
Ashkenazi Jewish (ASJ)
AF:
0.0158
AC:
382
AN:
24148
East Asian (EAS)
AF:
0.0000525
AC:
2
AN:
38060
South Asian (SAS)
AF:
0.00482
AC:
386
AN:
80120
European-Finnish (FIN)
AF:
0.00542
AC:
286
AN:
52750
Middle Eastern (MID)
AF:
0.0368
AC:
186
AN:
5054
European-Non Finnish (NFE)
AF:
0.0192
AC:
15975
AN:
831212
Other (OTH)
AF:
0.0166
AC:
833
AN:
50140
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
921
1841
2762
3682
4603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0117
AC:
1760
AN:
150704
Hom.:
17
Cov.:
30
AF XY:
0.0111
AC XY:
815
AN XY:
73432
show subpopulations
African (AFR)
AF:
0.00268
AC:
110
AN:
41104
American (AMR)
AF:
0.00969
AC:
147
AN:
15166
Ashkenazi Jewish (ASJ)
AF:
0.0145
AC:
50
AN:
3460
East Asian (EAS)
AF:
0.000391
AC:
2
AN:
5114
South Asian (SAS)
AF:
0.00526
AC:
25
AN:
4752
European-Finnish (FIN)
AF:
0.00539
AC:
54
AN:
10024
Middle Eastern (MID)
AF:
0.0393
AC:
11
AN:
280
European-Non Finnish (NFE)
AF:
0.0193
AC:
1308
AN:
67818
Other (OTH)
AF:
0.0130
AC:
27
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
84
169
253
338
422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00774
Hom.:
1
Bravo
AF:
0.0113
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Li-Fraumeni syndrome 1 (3)
-
-
3
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not specified (2)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Li-Fraumeni syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.017
DANN
Benign
0.68
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17880604; hg19: chr17-7577644; COSMIC: COSV52683791; API